Research Article | | Peer-Reviewed

Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea

Received: 28 October 2023     Accepted: 8 December 2023     Published: 5 February 2024
Views:       Downloads:
Abstract

Introduction: COVID-19 is an infectious respiratory disease that can be fatal in patients weakened by age or another chronic illness. Several means have been used to prevent this disease, including vaccination against COVID-19, which has also enabled us to protect the population against COVID-19. It began on 4 March 2021 in Guinea with front-line staff, with vulnerable people, those aged 60 and over, being the first beneficiaries. The low vaccination coverage of 3.5% led the Ministry of Health to organize two campaigns to accelerate vaccination against COVID-19 throughout the country. The first ran from 16 to 31 December 2021 and the second from 23 February to 13 March 2022. The aim of our study was to compare these two accelerated vaccination campaigns against COVID-19 to check whether all the recommendations had been considered. Methodology: This was a retrospective, analytical, cross-sectional study comparing two accelerated vaccination campaigns against COVID-19, carried out from 10 August to 20 September 2022 and involving all vaccinated persons entered in the DHIS2 software during the two accelerated vaccination campaigns against COVID-19: organized from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. The data collected in the two COVID-19 vaccination databases were exported using Excel and analyzed using SPSS version 24. Results: Our study enabled us to deduce that during the second campaign, vaccination coverage statistically doubled, that there was more vaccine available with the introduction of a new vaccine (Moderna), and that more MAPIs were notified (627) compared with (269) during the first campaign, all of which were light. The seizure rate was 23% compared with 13% in the first campaign. Conclusion: At the end of our study, we found that during the second campaign: Vaccination coverage improved, the number of MAPIs notified increased, the number of vaccines was more available in terms of quality and quantity, and there was an improvement in data entry. These results will enable us to prepare better for future campaigns.

Published in World Journal of Public Health (Volume 9, Issue 1)
DOI 10.11648/wjph.20240901.17
Page(s) 49-55
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Campaign, Vaccination, COVID-19, Comparison, Guinea

References
[1] WHO-2019-nCoV-vaccine-effectiveness-measurement-2021.1-eng.pdf [Internet]. [cited 25 Apr 2022]. Avalable from: https://apps.who.int/iris/bitstream/handle/10665/340950/WHO-2019-nCoV-vaccine-effectiveness-measurement-2021.1-fre.pdf?sequence=1&isAllowed=y
[2] Citi M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences. 17 August 2020; 57(6): 365-88.
[3] He F, Deng Y, Li W. Coronavirus disease 2019: What we know? Journal of Medical Virology. 2020; 92(7): 719-25.
[4] Lone SA, Ahmad A. COVID-19 pandemic - an African perspective. Emerging Microbes & Infections. 1 Jan 2020; 9(1): 1300-8.
[5] Mutabazi E. Does the COVID-19 pandemic call into question the citizenship of vulnerable people? Research & educations [Internet]. 11 May 2020 [cited 20 August 2021]; (HS). Available from: https://journals.openedition.org/rechercheseducations/9351
[6] Hansen JC, Charpentier JP, Martin R. COVID-19: should we be vaccinated? Risk fantasy and fantasized risk. Medicine De Catastrophe, Urgences Collectives. March 2021; 5(1): 105-10.
[7] Coronavirus disease 2019 (COVID-19): vaccines [Internet]. [cited 26 Apr 2022]. Available from: https://www.who.int/fr/news-room/questions-and-answers/item/coronavirus-disease-(COVID-19)-vaccines
[8] COVID-19 pandemic in the United States. In: Wikipedia [Internet]. 2022 [cited 8 Sep 2022]. Available from: https://fr.wikipedia.org/w/index.php?title=Pand%C3%A9mie_de_COVID-19_aux_%C3%89tats-Unis&oldid=196587332
[9] ICI. Radio-Canada.ca ZI. Where is vaccination in the world? Coronavirus [Internet]. Radio-Canada.ca. Radio-Canada.ca; [cited 21 Apr 2022]. Available from: https://ici.radio-canada.ca/nouvelle/1799808/vaccination-monde-COVID-pandemie-differences
[10] Vaccination against COVID-19 increases by 15% in Africa [Internet]. WHO Regional Office for Africa. 2023 [cited Feb 2023]. Available from: https://www.afro.who.int/fr/news/en-afrique-ladhesion-la-vaccination-contre-la-COVID-19-augmente-de-15
[11] Billon-Denis E, Tournier JN. COVID-19 and vaccination: a global deregulation. Med Sci (Paris). 1 Nov 2020; 36(11): 1034-7.
[12] In Africa, adherence to COVID-19 vaccination increases by 15% [Internet]. WHO Regional Office for Africa. [cited 29 Apr 2022]. Available from: https://www.afro.who.int/fr/news/en-afrique-ladhesion-la-vaccination-contre-la-COVID-19-augmente-de-15
[13] COVID-19: where does vaccination stand in Africa? [Internet]. TV5MONDE. 2021 [cited 21 Apr 2022]. Available from: https://information.tv5monde.com/afrique/COVID-19-ou-en-est-la-vaccination-en-afrique-420302
[14] Revised plan for the accelerated vaccination campaign against COVID-19.
[15] La Guinée dans la dynamique de la vaccination contre la COVID-19 [Internet]. Regional Office for Africa. [cited August 2021]. Available from: https://www.afro.who.int/fr/news/la-guinee-dans-la-dynamique-de-la-vaccination-contre-la-COVID-19
[16] Plan national de déploiement des vaccins 2022_VF.pdf.
[17] Rapport synthèse national de la première campagne accéléré covid 19 en Guinée.
[18] Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC, Galvani AP. The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States. Clin Infect Dis. 16 Dec 2021; 73(12): 2257-64.
[19] Lee H, Choe YJ, Kim S, Cho HK, Choi EH, Lee J, Bae H, Choi SR, You M. Attitude and Acceptance of COVID-19 Vaccine in Parents and Adolescents: A Nationwide Survey. J Adolesc Health. August 2022; 71(2): 164-71.
[20] Adverse reactions to COVID-19 vaccines [Internet]. [cited 26 Feb 2023]. Available from: https://www.who.int/fr/news-room/feature-stories/detail/side-effects-of-COVID-19-vaccines
[21] Summary report of the vaccination campaign against Covid-19 in the Nzerekore region.
[22] Vaccin COVID-19: un outil numérique pour le suivi de la vaccination [Internet]. [cited 28 Feb 2023]. Available from: https://www.ameli.fr/assure/COVID-19/vaccination-contre-le-COVID-19/vaccin-COVID-un-outil-numerique-pour-le-suivi-de-la-vaccination.
[23] Canada Public Health Agency. COVID-19: Sécurité des vaccines et effets secondaires liés à la vaccination [Internet]. 2021 [cited 27 Feb 2023]. Available from: https://www.canada.ca/fr/sante-publique/services/maladies/maladie-coronavirus-COVID-19/vaccins/securite-effets-secondaires.html.
[24] Les effets secondaires des vaccins sont plus graves que le COVID: vrai ou faux? La Croix [Internet]. 21 Jul 2021 [cited 26 Feb 2023]; Available from: https://www.la-croix.com/Sciences-et-ethique/effets-secondaires-vaccins-sont-graves-COVID-vrai-faux-2021-07-21-1201167283.
Cite This Article
  • APA Style

    Diallo, A. O., Sow, A., Bah, K., Sow, S., Kouame, J. K., et al. (2024). Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. World Journal of Public Health, 9(1), 49-55. https://doi.org/10.11648/wjph.20240901.17

    Copy | Download

    ACS Style

    Diallo, A. O.; Sow, A.; Bah, K.; Sow, S.; Kouame, J. K., et al. Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. World J. Public Health 2024, 9(1), 49-55. doi: 10.11648/wjph.20240901.17

    Copy | Download

    AMA Style

    Diallo AO, Sow A, Bah K, Sow S, Kouame JK, et al. Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. World J Public Health. 2024;9(1):49-55. doi: 10.11648/wjph.20240901.17

    Copy | Download

  • @article{10.11648/wjph.20240901.17,
      author = {Alpha Oumar Diallo and Abdoulaye Sow and Kadiata Bah and Sadou Sow and Jean Konan Kouame and Mamadou Oury Balde and Alain Ntumba Katende and Mamadou Alpha Diallo and Issiaga Konate and Jean Charlemagne Kondombo and Mariama Souare and Amadou Lamarana Sow and Mouctar Kande and Sekou Solano and Fode Bangaly Diakite and Mamadou Bhoye Diallo and Mamadou Pathe Bah and Amadou Bailo Diallo and Jean Marie Kipela},
      title = {Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea},
      journal = {World Journal of Public Health},
      volume = {9},
      number = {1},
      pages = {49-55},
      doi = {10.11648/wjph.20240901.17},
      url = {https://doi.org/10.11648/wjph.20240901.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.wjph.20240901.17},
      abstract = {Introduction: COVID-19 is an infectious respiratory disease that can be fatal in patients weakened by age or another chronic illness. Several means have been used to prevent this disease, including vaccination against COVID-19, which has also enabled us to protect the population against COVID-19. It began on 4 March 2021 in Guinea with front-line staff, with vulnerable people, those aged 60 and over, being the first beneficiaries. The low vaccination coverage of 3.5% led the Ministry of Health to organize two campaigns to accelerate vaccination against COVID-19 throughout the country. The first ran from 16 to 31 December 2021 and the second from 23 February to 13 March 2022. The aim of our study was to compare these two accelerated vaccination campaigns against COVID-19 to check whether all the recommendations had been considered. Methodology: This was a retrospective, analytical, cross-sectional study comparing two accelerated vaccination campaigns against COVID-19, carried out from 10 August to 20 September 2022 and involving all vaccinated persons entered in the DHIS2 software during the two accelerated vaccination campaigns against COVID-19: organized from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. The data collected in the two COVID-19 vaccination databases were exported using Excel and analyzed using SPSS version 24. Results: Our study enabled us to deduce that during the second campaign, vaccination coverage statistically doubled, that there was more vaccine available with the introduction of a new vaccine (Moderna), and that more MAPIs were notified (627) compared with (269) during the first campaign, all of which were light. The seizure rate was 23% compared with 13% in the first campaign. Conclusion: At the end of our study, we found that during the second campaign: Vaccination coverage improved, the number of MAPIs notified increased, the number of vaccines was more available in terms of quality and quantity, and there was an improvement in data entry. These results will enable us to prepare better for future campaigns.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Comparison of Two Accelerated Vaccination Campaigns Against COVID-19; from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea
    AU  - Alpha Oumar Diallo
    AU  - Abdoulaye Sow
    AU  - Kadiata Bah
    AU  - Sadou Sow
    AU  - Jean Konan Kouame
    AU  - Mamadou Oury Balde
    AU  - Alain Ntumba Katende
    AU  - Mamadou Alpha Diallo
    AU  - Issiaga Konate
    AU  - Jean Charlemagne Kondombo
    AU  - Mariama Souare
    AU  - Amadou Lamarana Sow
    AU  - Mouctar Kande
    AU  - Sekou Solano
    AU  - Fode Bangaly Diakite
    AU  - Mamadou Bhoye Diallo
    AU  - Mamadou Pathe Bah
    AU  - Amadou Bailo Diallo
    AU  - Jean Marie Kipela
    Y1  - 2024/02/05
    PY  - 2024
    N1  - https://doi.org/10.11648/wjph.20240901.17
    DO  - 10.11648/wjph.20240901.17
    T2  - World Journal of Public Health
    JF  - World Journal of Public Health
    JO  - World Journal of Public Health
    SP  - 49
    EP  - 55
    PB  - Science Publishing Group
    SN  - 2637-6059
    UR  - https://doi.org/10.11648/wjph.20240901.17
    AB  - Introduction: COVID-19 is an infectious respiratory disease that can be fatal in patients weakened by age or another chronic illness. Several means have been used to prevent this disease, including vaccination against COVID-19, which has also enabled us to protect the population against COVID-19. It began on 4 March 2021 in Guinea with front-line staff, with vulnerable people, those aged 60 and over, being the first beneficiaries. The low vaccination coverage of 3.5% led the Ministry of Health to organize two campaigns to accelerate vaccination against COVID-19 throughout the country. The first ran from 16 to 31 December 2021 and the second from 23 February to 13 March 2022. The aim of our study was to compare these two accelerated vaccination campaigns against COVID-19 to check whether all the recommendations had been considered. Methodology: This was a retrospective, analytical, cross-sectional study comparing two accelerated vaccination campaigns against COVID-19, carried out from 10 August to 20 September 2022 and involving all vaccinated persons entered in the DHIS2 software during the two accelerated vaccination campaigns against COVID-19: organized from 16 to 31 December 2021 and from 23 February to 13 March 2022 in the Republic of Guinea. The data collected in the two COVID-19 vaccination databases were exported using Excel and analyzed using SPSS version 24. Results: Our study enabled us to deduce that during the second campaign, vaccination coverage statistically doubled, that there was more vaccine available with the introduction of a new vaccine (Moderna), and that more MAPIs were notified (627) compared with (269) during the first campaign, all of which were light. The seizure rate was 23% compared with 13% in the first campaign. Conclusion: At the end of our study, we found that during the second campaign: Vaccination coverage improved, the number of MAPIs notified increased, the number of vaccines was more available in terms of quality and quantity, and there was an improvement in data entry. These results will enable us to prepare better for future campaigns.
    
    VL  - 9
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Medicine, Faculty of Health Sciences and Technology, University Gamal Abdel Nasser, Conakry, Guinea

  • Department of Medicine, Faculty of Health Sciences and Technology, University Gamal Abdel Nasser, Conakry, Guinea

  • Department of Medicine, Faculty of Health Sciences and Technology, University Gamal Abdel Nasser, Conakry, Guinea

  • Department of Medicine, Faculty of Health Sciences and Technology, University Gamal Abdel Nasser, Conakry, Guinea; World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • Department of Medicine, Faculty of Health Sciences and Technology, University Gamal Abdel Nasser, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • Regional Health Directorate, Labe, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • World Health Organization, Conakry, Guinea

  • Regional Health Directorate, Labe, Guinea

  • World Health Organization, Dakar Office, Dakar, Senegal

  • World Health Organization, Conakry, Guinea

  • Sections